Abstract
The prevalence of chronic obstructive pulmonary disease (COPD) is increasing and is now the third most common cause of death in the United States. It is estimated that half of all people in the United States with COPD have not been diagnosed, reflecting factors that include patient delay in seeking help despite symptoms and physician perception that only smoking cessation can improve the course of the disease. Primary care physicians are best placed to identify undiagnosed patients with mild or moderate COPD. Recent evidence from large randomized clinical trials demonstrates that pharmacologic treatments such as tiotropium and salmeterol/fluticasone can benefit patients with mild and moderate COPD, improving lung function, reducing the risk of exacerbations and improving health status. Primary care physicians can help patients and reduce the burden of COPD on healthcare systems by actively assessing patients they suspect may have COPD and treating those diagnosed.
Keywords: Chronic obstructive pulmonary disease, diagnosis, FEV1, smoking cessation, chronic smoking, Diagnosis of COPD
Current Respiratory Medicine Reviews
Title:Medical Treatment of COPD Patients with Mild and Moderate Airflow Obstruction
Volume: 8 Issue: 6
Author(s): Gary T. Ferguson and Leonard Fromer
Affiliation:
Keywords: Chronic obstructive pulmonary disease, diagnosis, FEV1, smoking cessation, chronic smoking, Diagnosis of COPD
Abstract: The prevalence of chronic obstructive pulmonary disease (COPD) is increasing and is now the third most common cause of death in the United States. It is estimated that half of all people in the United States with COPD have not been diagnosed, reflecting factors that include patient delay in seeking help despite symptoms and physician perception that only smoking cessation can improve the course of the disease. Primary care physicians are best placed to identify undiagnosed patients with mild or moderate COPD. Recent evidence from large randomized clinical trials demonstrates that pharmacologic treatments such as tiotropium and salmeterol/fluticasone can benefit patients with mild and moderate COPD, improving lung function, reducing the risk of exacerbations and improving health status. Primary care physicians can help patients and reduce the burden of COPD on healthcare systems by actively assessing patients they suspect may have COPD and treating those diagnosed.
Export Options
About this article
Cite this article as:
T. Ferguson Gary and Fromer Leonard, Medical Treatment of COPD Patients with Mild and Moderate Airflow Obstruction, Current Respiratory Medicine Reviews 2012; 8 (6) . https://dx.doi.org/10.2174/1573398X11208060009
DOI https://dx.doi.org/10.2174/1573398X11208060009 |
Print ISSN 1573-398X |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6387 |
Call for Papers in Thematic Issues
Exposure to PM2.5 components is associated with respiratory diseases
Through continuous research on the relationship between risk factors and health, it has been found that air pollution, especially atmospheric particulate matter pollution, has become one of the main sources of global disease burden. From 1990 to 2022, the concentration of atmospheric particulate matter pollution has increased by more than ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Exercise-induced Physiological Hypertrophy: Insights from Genomics
Current Genomics Multifactorial Regulation of GPER Expression in Cancer Cells and Cardiomyocytes
Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued) Teratological Consequences of Nitric Oxide Synthesis Inhibition
Current Pharmaceutical Design Mechanisms of Drug Induced QT Interval Prolongation
Current Drug Safety Adverse Effects of Statins - Mechanisms and Consequences
Current Drug Safety Nano-constructed Carriers Loaded With Antioxidant: Boon For Cardiovascular System
Current Pharmaceutical Design Atrial Fibrillation: The Emerging Role of Inflammation and Oxidative Stress
Cardiovascular & Hematological Disorders-Drug Targets Mitochondrial Proteases as Emerging Pharmacological Targets
Current Pharmaceutical Design Potential Role of Inflammation in Associations between Particulate Matter and Heart Failure
Current Pharmaceutical Design Beneficial Action of Citrus Flavonoids on Multiple Cancer-Related Biological Pathways
Current Cancer Drug Targets PCSK9 Inhibition - A Novel Mechanism to Treat Lipid Disorders?
Current Pharmaceutical Design Beta-Blockers in Pediatric Hypertrophic Cardiomyopathies
Reviews on Recent Clinical Trials Extranuclear Localization of SIRT1 and PGC-1α: An Insight into Possible Roles in Diseases Associated with Mitochondrial Dysfunction
Current Molecular Medicine Hypoxia-Inducible Factor-1 in Arterial Disease: A Putative Therapeutic Target
Current Vascular Pharmacology Lipid Management for the Prevention of Cardiovascular Disease
Current Pharmaceutical Design Biology of Cholesterol Lowering in Atherosclerotic Plaques
Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued) Neuroprotective and Preventative Effects of Molecular Hydrogen
Current Pharmaceutical Design Preterm Labour: An Overview of Current and Emerging Therapeutics
Current Medicinal Chemistry The Concept of Titration can be Transposed to Fluid Management. But does is Change the Volumes? Randomised Trial on Pleth Variability Index During Fast-Track Colonic Surgery
Current Clinical Pharmacology Copper Complexes as Anticancer Agents
Anti-Cancer Agents in Medicinal Chemistry